Results 1 to 10 of about 132,183 (303)

Diuretics in primary hypertension – Reloaded [PDF]

open access: yesIndian Heart Journal, 2016
Diuretics have long been cherished as drugs of choice for uncomplicated primary hypertension. Robust mortality and morbidity data is available for diuretics to back this strategy.
Sundeep Mishra
doaj   +2 more sources

UMOD Genotype and Clinical Outcomes in Heart Failure Patients Treated with Loop Diuretics: A UK Biobank Pharmacogenetic Cohort Study [PDF]

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Uromodulin (UMOD) regulates tubular sodium handling and modulates NKCC2, the molecular target of loop diuretics (LD). Although UMOD variants have been associated with blood pressure and hypertension, their pharmacogenetic relevance in heart failure (HF) remains unknown.
Reinhold Kreutz   +5 more
wiley   +2 more sources

Diuretics and Hypokalemia [PDF]

open access: yesActa Medica Iranica, 1970
We have studied hypokalemic action of different diuretics in a cooperative study on 28 patients and our results are as follows: I. 28 patients (18 male and 10 female) were the subject of our present study. 2. E. C. G.
Ali A. Handjani   +2 more
doaj   +3 more sources

Uricosuric diuretics [PDF]

open access: yesKidney International, 1980
Elevation of the serum urate is well recognized as an invariable side effect of treatment with all diuretics except those agents, such as triamterene and amiloride, that retain potassium. Practitioners cannot fail to appreciate the frequency of hyperuricemia in many of their patients because, even in asymptomatic patients, it is regularly brought to ...
Emmerson, Bryan T., Emmerson B.T.
openaire   +5 more sources

Association between changes in loop diuretic dose and outcomes in acute heart failure

open access: yesESC Heart Failure, 2023
Aims Little is known about the association between the starting of or dose changes in loop diuretics during acute heart failure (AHF) hospitalization and post‐discharge outcomes. We investigated the clinical impact of starting loop diuretics and changing
Yuta Seko   +27 more
doaj   +1 more source

Tactics of antihypertensive therapy during COVID-19 pandemic

open access: yesТерапевтический архив, 2021
Results of foreign and Russian studies indicate a higher mortality rate of patients with concomitant cardiovascular diseases (CVD) due to the new coronavirus infection COVID-19.
Valery I. Podzolkov   +4 more
doaj   +1 more source

Diuretics [PDF]

open access: yes, 2010
Diuretici su lijekovi koji smanjuju volumen ekstracelularne tekućine povećavanjem izlučivanja soli i vode putem bubrega. Mogu se podijeliti prema kemijskoj strukturi, mehanizmu i mjestu djelovanja: diuretici Henleove petlje (furosemid, bumetanid ...
Mavrić, Žarko   +2 more
core   +5 more sources

All diuretics used in the treatment of hypertension are not the same

open access: yesTürk Kardiyoloji Derneği Arşivi, 2017
Summary– Diuretics have been used for years to treat hypertension as both a monotherapy and in combination. Hydrochlorothiazide, indapamide, and chlorthalidone have frequently been considered in the same category as thiazide diuretics, but there is no ...
Serkan Asil, Enver Atalar
doaj   +1 more source

Impact of Albumin Binding Function on Pharmacokinetics and Pharmacodynamics of Furosemide

open access: yesMedicina, 2022
Background and Objectives: Albumin binding of the loop diuretic furosemide forms the basis for its transport to the kidney and subsequent tubular secretion, which is a prerequisite for its therapeutic effects.
Gerd Klinkmann   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy